Baidu
map

第十四届中国介入心脏病学大会在北京举行

2016-03-21 汤瑭 科学网

心脑血管疾病是人类死亡的主要原因之一,且致死率名列前位。据国家心血管病中心2014年发布的《中国心血管病报告2013》显示,每年约有350万人死于心血管病,每10秒钟就有一人死于该类疾病。因此,心血管疾病的研究与治疗方式受到社会各界的广泛关注。 目前随着技术的日趋成熟,微创介入治疗由于创伤小、治疗精准以及恢复快等优势,已逐渐成为临床治疗心血管疾病的最重要且有效的方法之一。 3 月18日,由中华

心脑血管疾病是人类死亡的主要原因之一,且致死率名列前位。据国家心血管病中心2014年发布的《中国心血管病报告2013》显示,每年约有350万人死于心血管病,每10秒钟就有一人死于该类疾病。因此,心血管疾病的研究与治疗方式受到社会各界的广泛关注。

目前随着技术的日趋成熟,微创介入治疗由于创伤小、治疗精准以及恢复快等优势,已逐渐成为临床治疗心血管疾病的最重要且有效的方法之一。

3 月18日,由中华医学会主办,国家心血管病中心、中国介入心脏病学大会理事会、中华医学会心血管病学分会和美国心血管研究基金会协办,欧洲心血管介入治疗协会(EAPCI)、美国心血管造影和介入学会(SCAI)、中国工程院医药卫生学部等共同支持的“第十四届中国介入心脏病学大会(CIT2016)”在北京举行。经皮冠状动脉介入治疗(PCI)、WATCHMAN左心耳封堵系统等多种当今全球先进的微创介入治疗方法亮相大会。心血管的钙化病变被介入医师公认为最复杂及最难处理的病变。由波士顿科学独家研发的旋磨技术能够充分打磨、消除阻碍支架送入和影响支架贴壁效果的钙化病变,可帮助医师完成整个复杂冠脉介入手术。旋磨技术开展至今已有20多年,在全球各地开展90万例之多,其有效性和安全性得到充分验证。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1970398, encodeId=d9b719e0398e5, content=<a href='/topic/show?id=6c9425269fd' target=_blank style='color:#2F92EE;'>#介入心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25269, encryptionId=6c9425269fd, topicName=介入心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 28 14:02:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018563, encodeId=b8f0201856373, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Dec 19 20:02:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73661, encodeId=cd7de3661aa, content=不错 要继续发扬, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160319/IMG56EC9696F32B05996.jpg, createdBy=0eac1630810, createdName=moonlight1, createdTime=Thu Mar 24 22:51:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73020, encodeId=afa3e3020da, content=的确不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:40:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72438, encodeId=591be24388c, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72110, encodeId=f553e2110ff, content=太好了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Mon Mar 21 13:28:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1970398, encodeId=d9b719e0398e5, content=<a href='/topic/show?id=6c9425269fd' target=_blank style='color:#2F92EE;'>#介入心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25269, encryptionId=6c9425269fd, topicName=介入心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 28 14:02:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018563, encodeId=b8f0201856373, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Dec 19 20:02:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73661, encodeId=cd7de3661aa, content=不错 要继续发扬, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160319/IMG56EC9696F32B05996.jpg, createdBy=0eac1630810, createdName=moonlight1, createdTime=Thu Mar 24 22:51:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73020, encodeId=afa3e3020da, content=的确不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:40:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72438, encodeId=591be24388c, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72110, encodeId=f553e2110ff, content=太好了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Mon Mar 21 13:28:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1970398, encodeId=d9b719e0398e5, content=<a href='/topic/show?id=6c9425269fd' target=_blank style='color:#2F92EE;'>#介入心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25269, encryptionId=6c9425269fd, topicName=介入心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 28 14:02:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018563, encodeId=b8f0201856373, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Dec 19 20:02:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73661, encodeId=cd7de3661aa, content=不错 要继续发扬, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160319/IMG56EC9696F32B05996.jpg, createdBy=0eac1630810, createdName=moonlight1, createdTime=Thu Mar 24 22:51:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73020, encodeId=afa3e3020da, content=的确不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:40:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72438, encodeId=591be24388c, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72110, encodeId=f553e2110ff, content=太好了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Mon Mar 21 13:28:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-24 moonlight1

    不错 要继续发扬

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1970398, encodeId=d9b719e0398e5, content=<a href='/topic/show?id=6c9425269fd' target=_blank style='color:#2F92EE;'>#介入心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25269, encryptionId=6c9425269fd, topicName=介入心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 28 14:02:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018563, encodeId=b8f0201856373, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Dec 19 20:02:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73661, encodeId=cd7de3661aa, content=不错 要继续发扬, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160319/IMG56EC9696F32B05996.jpg, createdBy=0eac1630810, createdName=moonlight1, createdTime=Thu Mar 24 22:51:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73020, encodeId=afa3e3020da, content=的确不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:40:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72438, encodeId=591be24388c, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72110, encodeId=f553e2110ff, content=太好了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Mon Mar 21 13:28:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-23 dhzzm

    的确不错,学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1970398, encodeId=d9b719e0398e5, content=<a href='/topic/show?id=6c9425269fd' target=_blank style='color:#2F92EE;'>#介入心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25269, encryptionId=6c9425269fd, topicName=介入心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 28 14:02:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018563, encodeId=b8f0201856373, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Dec 19 20:02:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73661, encodeId=cd7de3661aa, content=不错 要继续发扬, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160319/IMG56EC9696F32B05996.jpg, createdBy=0eac1630810, createdName=moonlight1, createdTime=Thu Mar 24 22:51:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73020, encodeId=afa3e3020da, content=的确不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:40:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72438, encodeId=591be24388c, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72110, encodeId=f553e2110ff, content=太好了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Mon Mar 21 13:28:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-21 milkshark

    的确不错

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1970398, encodeId=d9b719e0398e5, content=<a href='/topic/show?id=6c9425269fd' target=_blank style='color:#2F92EE;'>#介入心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25269, encryptionId=6c9425269fd, topicName=介入心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Sun Aug 28 14:02:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018563, encodeId=b8f0201856373, content=<a href='/topic/show?id=ff3c51599b0' target=_blank style='color:#2F92EE;'>#心脏病学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51599, encryptionId=ff3c51599b0, topicName=心脏病学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=640c454, createdName=qblt, createdTime=Mon Dec 19 20:02:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73661, encodeId=cd7de3661aa, content=不错 要继续发扬, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160319/IMG56EC9696F32B05996.jpg, createdBy=0eac1630810, createdName=moonlight1, createdTime=Thu Mar 24 22:51:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=73020, encodeId=afa3e3020da, content=的确不错,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Wed Mar 23 17:40:00 CST 2016, time=2016-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72438, encodeId=591be24388c, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Mon Mar 21 21:51:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72110, encodeId=f553e2110ff, content=太好了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b91679772, createdName=1de304d2m86(暂无匿称), createdTime=Mon Mar 21 13:28:00 CST 2016, time=2016-03-21, status=1, ipAttribution=)]
    2016-03-21 1de304d2m86(暂无匿称)

    太好了,学习

    0

相关资讯

心脏再同步化治疗(CRT)相关临床研究进展

 2012年3月1—3日,在广西南宁召开的第十五届全国介入心脏病学论坛上,浙江大学医学院附属第二医院王建安教授介绍了心脏再同步化治疗(CRT)相关临床研究进展情况。   王教授分别介绍了COMPANION研究、CARE—HF研究、REVERSE研究、MADIT CRT研究和RAFT研究,后三个研究共同证实了CRT可降低心功能分级(NYHA)Ⅱ级患者的死亡率或心衰事件,尤其是心脏再同步化并植入心

高润霖院士谈CIT大会发展 话介入成果

       导语:中国介入心脏病学大会(CIT)已走过10年风雨历程,她得了怎样的成长?对我国介入心脏病学的发展发挥了什么样的作用?介入心脏病学近年来取得了哪些成绩?且听高润霖院士娓娓道来。 高润霖院士     携手合作,共同发展     CIT大会迄今已走过10年的历

介入心脏病学的未来

文/Marie-Claude Morice, Amir-Ali Fassa 法国巴黎心血管研究所     在过去的20年间,尤其是提高了冠脉血运重建操作安全性的支架问世以来,经皮冠脉介入(PCI)的指征扩大了很多。千禧年伊始,药物洗脱支架的发展使冠脉疾病的经皮治疗得到了前所未有的改进,并实现了血管成形术的历史性突破。     目前,作

这10年,介入心脏病学在中国取得哪些发展?

  CIT 2012开幕式因恰逢CIT 10周岁生日而备显温馨、隆重,人们喜欢在这种特殊的日子回忆往事、重温友情,并畅想未来。马丁·莱昂(Martin Leon)教授感慨道,当初结识CIT时,无论参会人数还是会议日程设置都和现在有很大差距。当高润霖院士表示CIT始终并将进一步加强和国际学术组织(TCT等)密切合作、互通有无时,Leon教授回应说,CIT的成功是完全可以预见的。   冠脉领域,精益

Baidu
map
Baidu
map
Baidu
map